AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

RADIOPHARM THERANOSTICS LTD

0.006

-0.001-14.29%

Volume:1.28M

Turnover:9K

Market Cap:28.27M

PE:-0.34

High:0.007

Open:0.007

Low:0.006

Close:0.007

52wk High:0.040

52wk Low:0.006

Shares:4.71B

Float Shares:3.34B

Volume Ratio:0.24

T/O Rate:0.04%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.018

EPS(LYR):-0.018

ROE:-174.71%

ROA:-44.61%

PB:1.14

PE(LYR):-0.34

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Radiopharm Theranostics Ltd-Radoc New Class Options Range of Units and Top 20 Holders

THOMSON REUTERS

Radiopharm Theranostics Ltd-Share Purchase Plan Completed

THOMSON REUTERS

Radiopharm Says Interim Phase 2b Rad101 PET Trial Meets Primary Endpoint with 93% MRI Concordance

Press Release: Radiopharm Theranostics Selected for Late-Breaking Oral Presentation of Positive Data from Interim Analysis of U.S. Phase 2b Imaging Trial of Rad101 at 2026 Society of Neuro-Oncology Annual Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/RAD.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RAD.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RAD.AU\",,,,,undefined,":{"symbol":"RAD.AU","market":"AU","secType":"STK","nameCN":"RADIOPHARM THERANOSTICS LTD","latestPrice":0.006,"timestamp":1790748720000,"preClose":0.007,"halted":0,"volume":1284520,"delay":0,"changeRate":-0.14285714285714285,"nameEN":"RADIOPHARM THERANOSTICS LTD","floatShares":3342779849,"shares":4710883000,"eps":-0.0179,"marketStatus":"Not Yet Opened","change":-0.001,"latestTime":"09-30 16:12:00 AEST","open":0.007,"high":0.007,"low":0.006,"amount":8937,"amplitude":0.142857,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.0179,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1790812800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.007,"openAndCloseTimeList":[[1790726400000,1790748000000]],"volumeRatio":0.2442987604993971,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"RAD.AU","preClose":0.006,"auctionPrice":0.007,"auctionVolume":150000,"auctionTime":1790802050655,"referenceTime":1790764203089,"auction":1,"marketStatus":"盘前竞价","timestamp":1790802050655}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RAD.AU\",,,,,undefined,":{"symbol":"RAD.AU","floatShares":3342779849,"roa":"-44.61%","roe":"-174.71%","lyrEps":-0.0179,"volumeRatio":0.2442987604993971,"shares":4710883000,"dividePrice":0,"high":0.007,"amplitude":0.142857,"preClose":0.007,"low":0.006,"week52Low":0.006,"pbRate":"1.14","psRate":"2.09","week52High":0.04,"institutionHeld":0,"latestPrice":0.006,"eps":-0.0179,"divideRate":0,"volume":1284520,"delay":0,"ttmEps":-0.0179,"open":0.007,"prevYearClose":0.025,"prevWeekClose":0.008,"prevMonthClose":0.006,"prevQuarterClose":0.006,"fiveDayClose":0.007,"twentyDayClose":0.009,"sixtyDayClose":0.02,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RAD.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RAD.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RAD.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668934062","title":"Radiopharm Theranostics Ltd-Radoc New Class Options Range of Units and Top 20 Holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2668934062","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668934062?lang=en_us&edition=fundamental","pubTime":"2026-09-17 08:41","pubTimestamp":1789605709,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nTUE53N4TX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RAD.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668931040","title":"Radiopharm Theranostics Ltd-Share Purchase Plan Completed","url":"https://stock-news.laohu8.com/highlight/detail?id=2668931040","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668931040?lang=en_us&edition=fundamental","pubTime":"2026-09-17 08:11","pubTimestamp":1789603913,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nTUE2RCYWW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RAD.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667572665","title":"Radiopharm Says Interim Phase 2b Rad101 PET Trial Meets Primary Endpoint with 93% MRI Concordance","url":"https://stock-news.laohu8.com/highlight/detail?id=2667572665","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667572665?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:05","pubTimestamp":1789387544,"startTime":"0","endTime":"0","summary":"Radiopharm says interim Phase 2b RAD101 PET trial meets primary endpoint with 93% MRI concordanceRadiopharm Theranostics flagged positive interim Phase 2b imaging data for RAD101 in suspected recurren","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDL54ZDHc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","IE00B64PRP62.GBP","BK4112","IE00BQXX3D17.EUR","SG9999014039.USD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","SG9999014005.SGD","IE00BQXX3F31.USD","IE00BQXX3C00.GBP","LU2210149790.SGD","IE00BGHQF748.EUR","LU2210150020.SGD","IE00BN0W2T93.GBP","SG9999014013.SGD","BK7067","NDAQ","BK4585","LU2095319765.USD","BK4588","IE00BN0W2W23.USD","LU0314104364.USD","RAD.AU","IE00BN0W2V16.EUR","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667037663","title":"Press Release: Radiopharm Theranostics Selected for Late-Breaking Oral Presentation of Positive Data from Interim Analysis of U.S. Phase 2b Imaging Trial of Rad101 at 2026 Society of Neuro-Oncology Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2667037663","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667037663?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:00","pubTimestamp":1789387200,"startTime":"0","endTime":"0","summary":"RAD101 PET demonstrated 93% concordance with MRI across all evaluable lesions, meeting the trial's primary endpointMeeting with FDA planned on October 1(st) to align on RAD101Phase 3 pivotal trial pro","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SRS","RADX","BK7067","BK4139","RAD.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":18,"pageCount":1,"totalSize":71,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/RAD.AU\",params:#limit:6,delay:true,,,undefined,":[]}}